NCT05664126View on ClinicalTrials.gov

Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation

PHASE2RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
CytomegalovirusAdenovirus
Interventions
DRUG

VST infusion

single intravenous (IV) infusion.

DEVICE

CliniMACS

Cells infusions are prepared using the ClinMACS

Trial Locations (1)

38105

RECRUITING

St . Jude Children's Research Hospital, Memphis

All Listed Sponsors
lead

St. Jude Children's Research Hospital

OTHER